Teva, Mylan Secure Noninfringement Ruling in Delzicol Case

Teva Pharmaceutical USA Inc. and Mylan Pharmaceuticals Inc. may have moved closer to launching generic versions of Allergan Plc’s ulcer treatment Delzicol (Allergan Sales, LLC v. Teva Pharm. USA, Inc., 2017 BL 381848, E.D. Tex., No. 2:15-cv-01740-JRG-RSP, 10/24/17).

Mylan and Teva’s proposed generic versions of the drug, which treats mild to moderately active ulcerative colitis, didn’t infringe Allergan’s patent, Judge Rodney Gilstrap of the U.S. District for the Eastern District of Texas said in an Oct. 24 ruling. Water didn’t cause the film composition in the generic products to gel, a finding that would have been ...